Stock Groups

250,000 treatment courses of Pfizer anti-viral due in January -Breaking

by Mike Robinson

[ad_1]

© Reuters. U.S. President Joe Biden, his Supply Chain Disruptions Task Force, and CEOs from the private sector meet at White House Washington on December 22, 2021. REUTERS/Kevin Lamarque     

(Reuters) – U.S. President Joe Biden stated Wednesday that there were 250,000 courses for treatment. Pfizer (NYSE:) The newly approved COVID-19 antiviral drug, will be made available to the public in January. This includes the 10,000,000 courses that the United States pre-purchased.

Biden stated in a statement, that his administration will work with the states to make sure that treatment is distributed fairly and that those most affected are reached.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of the potential risks and financial costs involved in trading the financial market. It is one the most dangerous investment types.

[ad_2]